| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/17/2011 | US20110065647 Novel peptides isolated from spider venom, and uses thereof |
| 03/17/2011 | US20110065641 Polypeptide and dna thereof useful as a neovascular marker |
| 03/17/2011 | US20110065640 Anti-invasive and anti-angiogenic compositions |
| 03/17/2011 | US20110065627 Transdermal delivery of medicaments with combinations of cetylated fatty fatty ester penetrant complexes |
| 03/17/2011 | US20110065187 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065186 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065180 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases |
| 03/17/2011 | US20110064813 Use of salsalate with or without caffeine and with or without omega 3, and other pharmaceutical compounds in a distinctively unique nano-particulate capsule and tablet |
| 03/17/2011 | US20110064804 Methods and Compositions for the Treatment of CNS-Related Conditions |
| 03/17/2011 | US20110064797 Capsule of thermogenic cells for treating a metabolic disease |
| 03/17/2011 | US20110064796 Concentrated, inhalable antibiotic formulation |
| 03/17/2011 | US20110064762 Protein a compositions and methods of use |
| 03/17/2011 | US20110064757 Nucleic acid molecules and polypeptides for immune modulation |
| 03/17/2011 | US20110064752 Extracellular targeted drug conjugates |
| 03/17/2011 | US20110064748 Pharmaceutical combination and method for treating tumor |
| 03/17/2011 | US20110064746 Treatment of drug-related side effect and tissue damage by targeting the cd24-hmgb1-siglec10 axis |
| 03/17/2011 | US20110064737 ErbB ANTAGONISTS FOR PAIN THERAPY |
| 03/17/2011 | US20110064734 Prevention and treatment of amyloidogenic disease |
| 03/17/2011 | US20110064729 Administration of agents for the treatment of inflammation |
| 03/17/2011 | US20110064720 Dietary Supplement Compositions and Methods of Making and Using the Same |
| 03/17/2011 | US20110064715 Methods for determining oligosaccharide binding |
| 03/17/2011 | US20110064690 Pegylated Interleukin-10 |
| 03/17/2011 | US20110064677 Lipoxin analogs and methods for the treatment of periodontal disease |
| 03/17/2011 | US20110064671 Modulation of blood brain barrier permeability |
| 03/17/2011 | US20110062630 Cellulose powder having excellent segregation preventive effect, and compositions thereof |
| 03/17/2011 | US20110061345 Solid and semi-solid dosage forms and systems and methods for forming and packaging thereof |
| 03/17/2011 | CA2773957A1 Nutritional compositions for modulating inflammation including exogenous vitamin k2 |
| 03/17/2011 | CA2773940A1 Nutritional compositions including exogenous vitamin k2 |
| 03/17/2011 | CA2773590A1 8-oxodihydropurine derivative |
| 03/17/2011 | CA2773561A1 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same |
| 03/17/2011 | CA2773541A1 High affinity human antibodies to human protease-activated receptor-2 |
| 03/17/2011 | CA2773182A1 Inhibitors of jak |
| 03/16/2011 | EP2295550A2 Crystal structures of GSK-3beta protein and protein complexes and their use. |
| 03/16/2011 | EP2295529A2 Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295450A1 Pegylated interleukin-10 |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295435A1 Substituted porphyrins and their therapeutic use |
| 03/16/2011 | EP2295429A1 3-((hetero)aryl)-indazoles as Liver X receptor (LXR) and Th-1 inhibitors for the treatment of cardiovascular diseases |
| 03/16/2011 | EP2295413A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295412A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295408A1 Matrix metalloproteinase inhibitors |
| 03/16/2011 | EP2295404A2 Substituted tetracycline compounds |
| 03/16/2011 | EP2295081A1 Antibodies to OPGL |
| 03/16/2011 | EP2295079A2 Method for treating inflammation |
| 03/16/2011 | EP2295078A2 Method for treating inflammation |
| 03/16/2011 | EP2295067A1 E-selectin for inducing immunotolerance |
| 03/16/2011 | EP2295055A2 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof |
| 03/16/2011 | EP2295054A1 Ice inhibitors for the treatment of autoinflammatory diseases |
| 03/16/2011 | EP2295048A1 Synergistic anti-inflammatory pharmaceutical compositions comprising IAA and RIAA |
| 03/16/2011 | EP2294918A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 03/16/2011 | EP2294050A2 Bis-aryl compounds for use as medicaments |
| 03/16/2011 | EP2167470B1 Triazolo [1, 5-a]quinolines as adenosine a3 receptor ligands |
| 03/16/2011 | EP2155683B1 Pyridone derivatives as p38a mapk inhibitors |
| 03/16/2011 | EP2018388B1 Bisadenosine compounds as adenosine a2a receptor agonists |
| 03/16/2011 | EP1940827B1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 03/16/2011 | EP1841459B1 Use of a dihydroim1dazopyrazine derivative for treating or preventing pain |
| 03/16/2011 | EP1648878B9 Piperidine compounds and pharmaceutical compositions containing them |
| 03/16/2011 | EP1495018B3 Tricyclic thrombin receptor antagonists |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | CN101985480A Mussel polysaccharide and preparation method and application thereof |
| 03/16/2011 | CN101985467A Analgesic active peptide VGG and preparation method and applications thereof |
| 03/16/2011 | CN101985457A Medicinal salts of cordycepin and preparation method and medicinal application thereof |
| 03/16/2011 | CN101985438A Substituted phenyl piperazinyl aralkylone derivatives and application thereof to preparation of analgesics |
| 03/16/2011 | CN101985432A 3-Fmoc amino-3-(3-nitro-4-fluophenyl) propionic acid and preparation method thereof |
| 03/16/2011 | CN101985428A O-anilino benzoic acid derivatives or pharmaceutically acceptable salts thereof as well as preparation method and application thereof |
| 03/16/2011 | CN101985014A Pawpaw wine capable of relaxing tendons |
| 03/16/2011 | CN101985013A Chinese herbal medicine for treating rheumatic arthritis |
| 03/16/2011 | CN101984993A Chinese medicament for treating qi stagnation and blood stasis headache |
| 03/16/2011 | CN101984984A Chinese herbal medicine for treating lumbago due to blood stasis |
| 03/16/2011 | CN101984983A Lamiophlomis rotata extract, medicine composition containing same and quality control method thereof |
| 03/16/2011 | CN101984981A Linimentum containing mussel polysaccharide, preparation method and application thereof |
| 03/16/2011 | CN101984975A Medical composition containing cordycepin derivatives |
| 03/16/2011 | CN101700399B Traditional Chinese medicine ointment for treating lumbar muscle fasciitis |
| 03/16/2011 | CN101698058B Medicine for treating chronic arthralgia and preparation method thereof |
| 03/16/2011 | CN101647881B Medicine for treating fever of chicken |
| 03/16/2011 | CN101647878B Traditional Chinese medicine preparation for treating rheumatism and numbness |
| 03/16/2011 | CN101647865B Externally-applied medicine for treating traumatic injuries |
| 03/16/2011 | CN101618026B Meloxicam tablet, production technology and purposes thereof |
| 03/16/2011 | CN101584689B Compound eardrops containing antipyrine and lidocaine the and preparation method thereof |
| 03/16/2011 | CN101559063B External medicament for curing herpes zoster and preparation method thereof |
| 03/16/2011 | CN101550111B Preparation method of 2,5-bichlorphenyl-1,3,4-furodiazole |
| 03/16/2011 | CN101530436B Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity |
| 03/16/2011 | CN101491520B Local application medicine formulation |
| 03/16/2011 | CN101485808B Method for measuring naringin content in preparation for reunion of bone |
| 03/16/2011 | CN101475648B Preparation of Mallotus furetianus polysaccharide |
| 03/16/2011 | CN101347606B Chinese medicine plaster for treating rheumatism osteonosus and preparation method |
| 03/16/2011 | CN101342217B Quick-effective pain relieving traditional Chinese medicine liniment for treating advanced cancer and preparation method thereof |
| 03/16/2011 | CN101199833B Compound essential oil of releasing arthritis ache |
| 03/16/2011 | CN101199778B Compound medicament for treating synovitis |
| 03/16/2011 | CN101194944B Technique of preparing medicament for treating upper respiratory tract infection and quality control method |
| 03/16/2011 | CN101084951B Medicine for treating diseases concerned with respiratory and preparation method and application thereof |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906644 2,4-pyrimidinediamine compounds and their uses |
| 03/15/2011 | US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 03/15/2011 | US7906518 Therapeutic compounds |
| 03/15/2011 | US7906516 Carbonyl compounds |